Online English Summarizer tool, free and accurate!
The U.S. Food and Drug Administration (FDA) approved exagamglogene autotemcel (exa-cel) and lovotibeglogene autotemcel (lovo-cel) for the treatment of sickle cell disease (SCD) in patients 12 years or older."These approvals represent an important medical advance with the use of innovative cell-based gene therapies to target potentially devastating diseases and improve public health," said Peter Marks, MD, PhD, director of the FDA's Center for Biologics Evaluation and Research.Approved in the treatment of patients with SCD with recurrent vaso-occlusive crises, exa-cel increases the production of fetal hemoglobin and prevents the sickling of red blood cells.Much like exa-cel, this treatment is indicated for patients with SCD and a history of vaso-occlusive crises.
The U.S. Food and Drug Administration (FDA) approved exagamglogene autotemcel (exa-cel) and lovotibeglogene autotemcel (lovo-cel) for the treatment of sickle cell disease (SCD) in patients 12 years or older. They are the first cell-based gene therapies to receive approval as SCD treatments.
Exa-cel is a cell-based gene therapy that modifies hematopoietic stem cells (HSCs) via genome editing using CRISPR/Cas9 technology. This is the first therapy using CRISPR/Cas9 technology to be approved by the FDA.
Approved in the treatment of patients with SCD with recurrent vaso-occlusive crises, exa-cel increases the production of fetal hemoglobin and prevents the sickling of red blood cells. After the HSCs are modified, they are engrafted within the bone marrow.
Lovo-cel is another cell-based gene therapy that uses a lentiviral vector for genetic modification. With this treatment, HSCs are modified to produce HbAT87Q, which works similarly to hemoglobin A. Lovo-cel reduces the risk of sickling and occluded blood flow. Much like exa-cel, this treatment is indicated for patients with SCD and a history of vaso-occlusive crises.
For both exa-cel and lovo-cel, patients will receive myeloablative conditioning post-HSC collection before treatment.
“These approvals represent an important medical advance with the use of innovative cell-based gene therapies to target potentially devastating diseases and improve public health,” said Peter Marks, MD, PhD, director of the FDA’s Center for Biologics Evaluation and Research.
Summarize English and Arabic text using the statistical algorithm and sorting sentences based on its importance
You can download the summary result with one of any available formats such as PDF,DOCX and TXT
ٌYou can share the summary link easily, we keep the summary on the website for future reference,except for private summaries.
We are working on adding new features to make summarization more easy and accurate
توصلت الدراسة إلى أن رقمنة القطاع الصحي والصحة الإلكترونية لم تعودا خياراً ترفيهياً أو شكلياً، فقد أ...
مقدمة قال المصطفى خير الأنام صلى الله عليه وسلم في حديثه الشريف "اطلبوا العلم من المهد إلى ا...
يُعدّ القانون الجمركي من الفروع القانونية التي تهدف إلى حماية المصالح الاقتصادية والمالية للدولة من ...
such as drug design and development and toxicological and pharmacological trials of drugs. Similarly...
الملخص: تناقش الدراسة ثنائية الحضور والغياب في النقد الحديث وتأثيرها على شعر عبد الرحيم محمود وتجربت...
.5 להיווצרות אבנים בדרכי השתן מספר סיבות עיקריות, לכל אחת דרך מניעה מותאמת: א. ירידה בנפח השתן כתוצא...
حذرت مؤسسة "عراق المستقبل" للدراسات والاستشارات الاقتصادية، اليوم الجمعة، من تداعيات خفض قيمة الدينا...
وتتناول الاستراتيجية كافة أسس نظام الصحّة النفسية بهدف تحسين صحّة الأفراد النفسية بشكل عام والوقاية ...
As a core component of the combustor, the gas turbine swirler’s thermomechanical behavior directly i...
لاستراتيجية الوطنية للصحة النفسية 2024-2030 ملخّّص تنفيذي يمكننا القيام بالكثير ولكلّّ منا دوره في ...
الليلة الأولى وصلت أيها الشيخ - أطال الله حياتك - أول ليلة إلى مجلس الوزير - أعز الله نصره، وشد بال...
الليلة الأولى وصلت أيها الشيخ - أطال الله حياتك - أول ليلة إلى مجلس الوزير - أعز الله نصره، وشد بال...